Get the Stockscreener App
2.16
0.46%
-0.010
After Hours:
2.26
0.10
+4.63%
Xortx Therapeutics Inc stock is traded at $2.16, with a volume of 42,046.
It is down -0.46% in the last 24 hours and up +7.73% over the past month.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
See More
Previous Close:
$2.17
Open:
$2.09
24h Volume:
42,046
Relative Volume:
1.39
Market Cap:
$3.01M
Revenue:
-
Net Income/Loss:
$-2.66M
P/E Ratio:
-0.7199
EPS:
-3.0006
Net Cash Flow:
$-2.83M
1W Performance:
-23.13%
1M Performance:
+7.73%
6M Performance:
-50.90%
1Y Performance:
-52.00%
1-Day Range:
$2.03
$2.17
1-Week Range:
$2.01
$2.78
52-Week Range:
$1.725
$7.05
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
2.16 | 3.02M | 0 | -2.66M | -2.83M | -3.0006 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
Discontinued operations of XORTX Therapeutics, Inc. – DUS:ANU - TradingView — Track All Markets
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – DUS:ANU - TradingView — Track All Markets
Xortx announces closing of acquisition of Vectus kidney anti-fibrotic asset - marketscreener.com
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset - The Manila Times
Hedge Fund Moves: What is the target price for XORTX Therapeutics Inc stockProduct Launch & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is XORTX Therapeutics Inc vulnerable to short sellers2026 Price Action Summary & Real-Time Volume Analysis - baoquankhu1.vn
XORTX Therapeutics : Investor Presentation - marketscreener.com
Aug Update: Can XORTX Therapeutics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Bond Watch: Is XORTX Therapeutics Inc a speculative investmentWall Street Watch & Low Risk Entry Point Tips - baoquankhu1.vn
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – TRADEGATE:ANU - TradingView — Track All Markets
XORTX Therapeutics Inc. R (ANUA.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
XORTX Therapeutics, Inc. Revenue Breakdown – LS:A427MJ - TradingView
Gross margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Tangible book value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LS:A427MJ - TradingView — Track All Markets
Operating cash flow per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Dividends – LS:A427MJ - TradingView — Track All Markets
Discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Operating margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
EBITDA margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Gross profit of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Cash from investing activities of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Cash Flow – LSX:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Cash Flow – LS:A427MJ - TradingView — Track All Markets
Net income before discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Non-operating income (total) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
EBIT per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
EBITDA margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Net margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Enterprise value to EBITDA ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Net current asset value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Operating margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to sales ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Debt to assets ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to cash flow ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Price to cash flow ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Diluted shares outstanding of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Tangible book value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Price to book ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Return on equity % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
CapEx per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Total common shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
XORTX Therapeutics, Inc. Statistics – LS:A427MJ - TradingView — Track All Markets
Total revenue of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Equity in earnings of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView — Track All Markets
Diluted shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView — Track All Markets
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):